The 12 closest competitors and alternatives to Kamari Pharma among pharmaceuticals companies — ranked by similarity to what Kamari Pharma actually does, not by market-cap band.
Subscribe to see Kamari Pharma’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Kamari Pharma (now Orvida Pharma) is a privately held biopharmaceutical company located at the Weizmann Science Park in Ness Ziona, Israel, focused on developing therapeutic treatments.
Kamari Pharma is a pharmaceuticals company headquartered in Israel. Its most recent funding round, Series A, raised $23M in June 2025. Xcout tracks 10 named people at Kamari Pharma, including David Aviezer (CEO).
4 more named people on record for Kamari Pharma, with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $23M | 10 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Ranked by semantic similarity — how close each company is to Kamari Pharma by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar pharmaceuticals company
Wize Pharma, Inc. is a clinical-stage biopharmaceutical company headquartered in Hod Hasharon, Israel. The company focuses on the development and commercialization of treatments for ophthalmic and other serious medical conditions.
Biotech, Pharmaceuticals
Kamada Ltd. is a biopharmaceutical firm focused on developing, manufacturing, and distributing protein therapeutics derived from human plasma. The company operates through two core business areas: its proprietary product segment and its distribution division. Its own manufactured portfolio includes KAMRAB/KEDRAB for rabies prevention, CYTOGAM to prevent cytomegalovirus disease in transplant recipients, WINRHO SDF for immune thrombocytopenic purpura and Rhesus (Rh) isoimmunization, HEPAGAM B for hepatitis B recurrence prevention following liver transplants and for post-exposure prophylaxis, VARIZIG for post-exposure chickenpox prophylaxis, and GLASSIA for intravenous alpha-1 antitrypsin deficiency (AATD). Kamada also produces KamRho (D) for the prophylaxis of hemolytic disease of newborns and immune thrombocytopenic purpura, along with a specific antiserum for Vipera palaestinae and Echis coloratus snake bites. Additionally, the company distributes a wide array of third-party pharmaceutical products, encompassing treatments like BRAMITOB for chronic pulmonary infections, FOSTER for asthma, PROVOCHOLINE for diagnosing bronchial airway hyperactivity, and specialized therapies such as IVIG for immunodeficiency, VARITECT for chickenpox and zoster herpes, and various factors for hemophilia A and B, among numerous others for conditions like hepatitis B, cytomegalovirus, angioedema, Japanese encephalitis, and prostate cancer. Kamada markets its offerings in the United States through strategic partners and internationally via a network of distributors. The company maintains significant collaborations with Takeda Pharmaceuticals Company Limited, PARI GmbH, and Kedrion Biopharma. Established in 1990, Kamada Ltd. is headquartered in Rehovot, Israel.
Similar pharmaceuticals company
RDD Pharma Ltd. is a biopharmaceutical company focused on the discovery and development of therapeutic products for gastrointestinal and anorectal diseases. Headquartered in Israel with locations in Tel Aviv and Ofakim, the company specializes in targeted treatments.
Similar pharmaceuticals company
Abital Pharma is an Israeli therapeutics company founded in 2012 by Prof. Moussa B. H. Youdim, focusing on the development of original drugs and operating as a life science incubator.
Similar pharmaceuticals company
Pharma Two B Ltd. is a late-clinical stage biopharmaceutical company headquartered in Kiryat Ono, Israel. The company focuses on developing pharmaceutical treatments and therapeutic products for neurological and related medical conditions. It has pursued corporate growth initiatives, including planned public market transactions via mergers.
Pharma
Kashiv BioSciences is a vertically integrated biopharmaceutical company with global R&D, clinical, manufacturing, regulatory, and IP capabilities, maintaining its headquarters in Bridgewater, New Jersey.
Similar pharmaceuticals company
Pain Reform Ltd. is a specialty pharmaceutical and diversified innovation company advancing therapeutic treatments and clinical trials, with executive leadership operating out of Israel.
Similar pharmaceuticals company
SciSparc Ltd. is a pharmaceutical company in the clinical development phase, specializing in creating medications derived from cannabinoid molecules. Their therapeutic pipeline encompasses several key drug candidates: SCI-110, which is being investigated for the treatment of Tourette syndrome, obstructive sleep apnea, and agitation associated with Alzheimer's disease; SCI-160, designed to address pain; and SCI-210, targeting autism spectrum disorder and epilepsy. The company has formed strategic alliances to further its goals. A partnership with Procaps focuses on the development and eventual commercial manufacturing of SCI-110, as well as CannAmide, an oral palmitoylethanolamide in a soft gel capsule. SciSparc is also collaborating with the Sheba Fund for Health Services and Research to explore SCI-210's potential in managing status epilepticus. Additionally, it has teamed up with The Israeli Medical Center for Alzheimer's to conduct a Phase IIa clinical trial, evaluating the safety, tolerability, and effectiveness of SCI-110 for patients experiencing Alzheimer's disease and agitation. Founded in 2004, the company initially operated under the name Therapix Biosciences Ltd. before changing to SciSparc Ltd. in January 2021. Its main corporate office is located in Tel Aviv-Yafo, Israel.
Similar pharmaceuticals company
Orion Corporation, founded in 1917 and headquartered at Espoo, Finland, is a globally operating Finnish company which develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients for global markets. All of the company's manufacturing sites and the majority of its R&D units are in Finland.
Similar pharmaceuticals company
Hanmi Pharmaceutical Co., Ltd. is a South Korean pharmaceutical company that develops, manufactures, and commercializes prescription medicines, including products for areas such as oncology, metabolic disorders, and cardiovascular disease. It serves patients and healthcare providers in South Korea and international markets, with a significant focus on drug research and development.
Similar pharmaceuticals company
Solaris Pharma Corporation is a specialty pharmaceutical company founded in 2014 and located in Bridgewater, New Jersey.
Similar pharmaceuticals company
Mapi Pharma is an Israeli pharmaceutical company that develops complex generic and proprietary drug products, with a focus on long-acting injectable formulations. Its products are intended for patients and healthcare providers, and the company works with pharmaceutical partners to develop and commercialize treatments, including therapies for neurological conditions such as multiple sclerosis.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Kamari Pharmaand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →